# Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

> **NCT06069622** · — · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DIAGNOSTIC_TEST:** 24-hour ambulatory blood pressure
- **DIETARY_SUPPLEMENT:** Liberal salt diet

## Key facts

- **NCT ID:** NCT06069622
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-11-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069622, "Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06069622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*